# Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers

> **NCT02718625** · PHASE4 · TERMINATED · sponsor: **Smith & Nephew, Inc.** · enrollment: 3 (actual)

## Conditions studied

- Pressure Ulcer

## Interventions

- **BIOLOGICAL:** Santyl
- **BIOLOGICAL:** SoloSite®

## Key facts

- **NCT ID:** NCT02718625
- **Lead sponsor:** Smith & Nephew, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-08
- **Primary completion:** 2017-03-09
- **Final completion:** 2017-03-09
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Business Decision
- **Last updated:** 2020-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02718625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02718625, "Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02718625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*